ADC THERAPEUTICS SA shareholders Q1 2023

ADC THERAPEUTICS SA's ticker is ADCT and the CUSIP is H0036K147. A total of 61 filers reported holding ADC THERAPEUTICS SA in Q1 2023. The put-call ratio across all filers is 16.86 and the average weighting 0.2%.

ADC THERAPEUTICS SA shareholders Q1 2023
NameSharesValueWeighting ↓
Prosight Management, LP 3,257,360$6,351,8523.01%
Sio Capital Management, LLC 2,160,632$4,213,2322.08%
Vantage Consulting Group Inc 1,186,215$2,313,1191.31%
Redmile Group, LLC 13,565,249$26,452,2361.15%
AlphaCentric Advisors LLC 760,000$1,482,0001.02%
Blue Owl Capital Holdings LP 733,568$1,430,4580.92%
Affinity Asset Advisors, LLC 600,000$1,170,0000.39%
Frazier Life Sciences Management, L.P. 1,647,030$3,211,7090.23%
GCM Grosvenor Holdings, LLC 410,888$801,2320.22%
Indie Asset Partners, LLC 93,839$182,9860.21%
Nantahala Capital Management 840,000$1,638,0000.13%
XTX Topco Ltd 266,259$519,2050.11%
Perceptive Advisors 1,495,805$2,916,8200.09%
Eventide Asset Management 1,675,959$3,268,1200.06%
Values First Advisors, Inc. 13,019$25,3880.02%
Hennion & Walsh Asset Management, Inc. 57,066$1110.01%
GSA CAPITAL PARTNERS LLP 23,648$460.01%
Woodline Partners LP 143,403$279,6360.00%
PICTET ASSET MANAGEMENT SA 1,366,689$2,665,0440.00%
Dynamic Technology Lab Private Ltd 14,332$280.00%
External links

This page lists ADC THERAPEUTICS SA's shareholders in Q1 2023. To view ADC THERAPEUTICS SA's shareholder history, click here.